Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Aug 9;11(8):e050739.
doi: 10.1136/bmjopen-2021-050739.

Combined association of obesity and other cardiometabolic diseases with severe COVID-19 outcomes: a nationwide cross-sectional study of 21 773 Brazilian adult and elderly inpatients

Natanael de Jesus Silva  1   2 , Rita de Cássia Ribeiro-Silva  3   2   4 , Andrêa Jacqueline Fortes Ferreira  3   2   5 , Camila Silveira Silva Teixeira  3   2   5 , Aline Santos Rocha  3   2   4 , Flávia Jôse Oliveira Alves  3   2   5 , Ila Rocha Falcão  2 , Elizabete de Jesus Pinto  2   6 , Carlos Antônio de Souza Teles Santos  3   2   7 , Rosemeire Leovigildo Fiaccone  3   2   8 , Maria Yury Travassos Ichihara  3   2 , Enny S Paixão  3   2   9 , Mauricio L Barreto  3   2   5
Affiliations

Combined association of obesity and other cardiometabolic diseases with severe COVID-19 outcomes: a nationwide cross-sectional study of 21 773 Brazilian adult and elderly inpatients

Natanael de Jesus Silva et al. BMJ Open. .

Abstract

Objectives: To investigate the combined association of obesity, diabetes mellitus (DM) and cardiovascular disease (CVD) with severe COVID-19 outcomes in adult and elderly inpatients.

Design: Cross-sectional study based on registry data from Brazil's influenza surveillance system.

Setting: Public and private hospitals across Brazil.

Participants: Eligible population included 21 942 inpatients aged ≥20 years with positive reverse transcription-PCR test for SARS-CoV-2 until 9 June 2020.

Main outcome measures: Severe COVID-19 outcomes were non-invasive and invasive mechanical ventilation use, intensive care unit (ICU) admission and death. Multivariate analyses were conducted separately for adults (20-59 years) and elders (≥60 years) to test the combined association of obesity (without and with DM and/or CVD) and degrees of obesity with each outcome.

Results: A sample of 8848 adults and 12 925 elders were included. Among adults, obesity with DM and/or CVD showed higher prevalence of invasive (prevalence ratio 3.76, 95% CI 2.82 to 5.01) and non-invasive mechanical ventilation use (2.06, 1.58 to 2.69), ICU admission (1.60, 1.40 to 1.83) and death (1.79, 1.45 to 2.21) compared with the group without obesity, DM and CVD. In elders, obesity alone (without DM and CVD) had the highest prevalence of ICU admission (1.40, 1.07 to 1.82) and death (1.67, 1.00 to 2.80). In both age groups, obesity alone and combined with DM and/or CVD showed higher prevalence in all outcomes than DM and/or CVD. A dose-response association was observed between obesity and death in adults: class I 1.32 (1.05 to 1.66), class II 1.41 (1.06 to 1.87) and class III 1.77 (1.35 to 2.33).

Conclusions: The combined association of obesity, diabetes and/or CVD with severe COVID-19 outcomes may be stronger in adults than in elders. Obesity alone and combined with DM and/or CVD had more impact on the risk of COVID-19 severity than DM and/or CVD in both age groups. The study also supports an independent relationship of obesity with severe outcomes, including a dose-response association between degrees of obesity and death in adults.

Keywords: COVID-19; diabetes & endocrinology; epidemiology; infectious diseases; intensive & critical care; nutrition & dietetics.

PubMed Disclaimer

Conflict of interest statement

Competing interests: None declared.

Figures

Figure 1
Figure 1
Selection of the study population from SIVEP-Gripe. BMI, body mass index; ICU, intensive care unit; SIVEP-Gripe, Influenza Epidemiological Surveillance Information System.
See this image and copyright information in PMC

References

    1. World Health Organization . WHO coronavirus disease (COVID-19) dashboard. Available: https://covid19.who.int/ [Accessed 11 Jul 2021].
    1. Centers for Disease Control and Prevention . Coronavirus disease 2019 (COVID-19). People who are at increased risk for severe illness. Available: https://www.cdc.gov/coronavirus/2019-ncov/need-extra-precautions/people-... [Accessed 21 Jul 2020].
    1. Liu H, Chen S, Liu M, et al. Comorbid chronic diseases are strongly correlated with disease severity among COVID-19 patients: a systematic review and meta-analysis. Aging Dis 2020;11:668–78. 10.14336/AD.2020.0502 - DOI - PMC - PubMed
    1. Alberca RW, Oliveira LdeM, Branco ACCC. Obesity as a risk factor for COVID-19: an overview. Crit Rev Food Sci Nutr 2021;61:2262–76. 10.1080/10408398.2020.1775546 - DOI - PubMed
    1. Sattar N, McInnes IB, McMurray JJV. Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms. Circulation 2020;142:4–6. 10.1161/CIRCULATIONAHA.120.047659 - DOI - PubMed

Publication types